STRATA Skin Sciences (SSKN) Gains from Investment Securities (2016 - 2025)
STRATA Skin Sciences (SSKN) has disclosed Gains from Investment Securities for 13 consecutive years, with -$9000.0 as the latest value for Q4 2025.
- Quarterly Gains from Investment Securities fell 100.89% to -$9000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $989000.0 through Dec 2025, down 7.48% year-over-year, with the annual reading at $536826.0 for FY2025, 2.89% up from the prior year.
- Gains from Investment Securities hit -$9000.0 in Q4 2025 for STRATA Skin Sciences, down from $16576.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $7.3 million in Q3 2024 to a low of -$17000.0 in Q1 2022.
- Historically, Gains from Investment Securities has averaged $2.2 million across 5 years, with a median of $713363.0 in 2023.
- Biggest five-year swings in Gains from Investment Securities: skyrocketed 16980.12% in 2021 and later crashed 123.94% in 2023.
- Year by year, Gains from Investment Securities stood at $73000.0 in 2021, then fell by 2.74% to $71000.0 in 2022, then crashed by 123.94% to -$17000.0 in 2023, then skyrocketed by 6070.59% to $1.0 million in 2024, then tumbled by 100.89% to -$9000.0 in 2025.
- Business Quant data shows Gains from Investment Securities for SSKN at -$9000.0 in Q4 2025, $16576.0 in Q3 2025, and $238000.0 in Q2 2025.